George H Nashick, MD in Bayboro, NC - General Practice

George H Nashick, MD is a General Practice physician based in Bayboro, North Carolina. George H Nashick is licensed to practice in North Carolina (license number 20564) and his current practice location is 606 Main St, Bayboro, North Carolina. He can be reached at his office (for appointments etc.) via phone at (252) 745-3191.

NPI number for George H Nashick is 1841233814 and his current mailing address is Po Box 729, 606 Mainst, Bayboro, North Carolina. He does not participate in medicare program and thus does not accept medicare assignments. His NPI Number is 1841233814.

Contact Information

	George H Nashick, MD
	606 Main St, Bayboro, NC 28515-9632
	(252) 745-3191
	(252) 745-7385

Physician's Profile

Full Name	George H Nashick
Gender	Male
Speciality	General Practice
Location	606 Main St, Bayboro, North Carolina
Accepts Medicare Assignments	Does not participate in Medicare Program. He may not accept medicare assignment.

NPI Data:

NPI Number: 1841233814
Provider Enumeration Date: 06/14/2006
Last Update Date: 07/08/2007

Medical Identifiers

Medical identifiers for George H Nashick such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1841233814	NPI	-	NPPES
7961882	Medicaid	NC

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
208D00000X	General Practice	20564 (North Carolina)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. George H Nashick is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
George H Nashick, MD Po Box 729, 606 Mainst, Bayboro, NC 28515-0729 Ph: (252) 745-3191	George H Nashick, MD 606 Main St, Bayboro, NC 28515-9632 Ph: (252) 745-3191

News Archive

A Multi-Modal Approach for the Early Detection of Breast Cancer

Professor Samir Iqbal describes his research in the field of breast cancer detection and how machine learning can improve early diagnosis rates.

Can-Fite BioPharma opens CF101 IND for psoriasis with US FDA

Can-Fite BioPharma Ltd, a biotechnology company traded on the Tel Aviv Stock Exchange, announced today that it has opened Investigational New Drug application (IND) with the United States Food and Drug Administration (US FDA). The IND is for Can-Fite's lead compound, CF101, for the treatment of patients with psoriasis. This is the third US IND for CF101, and the fourth for Can-Fite.

Free webinar to help people with written expression deficits

Two experts who specialize in empowering families and professionals with the knowledge of affordable technologies to maximize success are offering a free webinar about resources to support people who have written expression deficits.

GlobalPost reports on second round GHI country selections

GlobalPost's "Global Pulse" blog reports on the addition of 21 countries to the original group of eight Global Health Initiative (GHI) countries in a second round of selections. The Obama administration has "review[ed] detailed plans from each on main strategies and goals," according to U.S. officials, the blog reports.

Insight into how cancerous tumors thrive

Using mathematical theory, UC Irvine scientists have shed light on one of cancer's most troubling puzzles - how cancer cells can alter their own genetic makeup to accelerate tumor growth.

George H Nashick, MD - General Practice in Bayboro, NC